Vesterqvist O and Gréen K |
Effects of naproxen on the in vivo synthesis of thromboxane and prostacyclin in man. |
1989 |
Eur. J. Clin. Pharmacol. |
pmid:2515064
|
Vesterqvist O |
Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Evidence from measurements of the major urinary metabolite of prostacyclin by GC-MS. |
1986 |
Eur. J. Clin. Pharmacol. |
pmid:3519239
|
Larsson PT et al. |
Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation. |
1992 |
Eur. J. Clin. Pharmacol. |
pmid:1387607
|
Lahoz C et al. |
Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. |
1997 |
Eur. J. Clin. Invest. |
pmid:9352251
|
Ross S et al. |
Association of cyclooxygenase-2 genetic variant with cardiovascular disease. |
2014 |
Eur. Heart J. |
pmid:24796340
|
Closa D et al. |
Changes of systemic prostacyclin and thromboxane A2 in sodium taurocholate- and cerulein-induced acute pancreatitis in rats. |
1993 |
Dig. Dis. Sci. |
pmid:7678383
|
Koivisto VA et al. |
Stimulation of prostacyclin synthesis by physical exercise in type I diabetes. |
1989 |
Diabetes Care |
pmid:2507264
|
Rautanen M et al. |
Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs. |
1997 |
Crit. Care Med. |
pmid:9233750
|
Watson ML et al. |
Prostaglandins and kallikrein during volume expansion in normal man. |
1984 |
Contrib Nephrol |
pmid:6570094
|
Wennmalm A et al. |
2,3-Dinor metabolites of thromboxane A2 and prostacyclin in urine from healthy human subjects: diurnal variation and relation to 24h excretion. |
1992 |
Clin. Sci. |
pmid:1330409
|